Literature DB >> 10985984

Paraneoplastic rheumatic syndromes.

A G Fam1.   

Abstract

Malignant neoplasms are associated with a wide variety of paraneoplastic rheumatological syndromes. Among these, hypertrophic osteoarthropathy, carcinoma polyarthritis, dermatomyositis/polymyositis, and paraneoplastic vasculitis are the most frequently recognized. Other less known associations are based upon a smaller number of reported patients, and include fasciitis, panniculitis, erythema nodosum, Raynaud's syndrome, digital gangrene, erythromelalgia and lupus-like syndromes. Musculoskeletal manifestations of malignancy may coincide, follow or antedate the diagnosis of cancer, or herald its recurrence. The clinical course generally parallels that of the primary tumour, and treatment of the underlying malignancy often results in regression of the rheumatic disorder. Awareness that cancer can cause certain non-metastatic symptoms is important for early diagnosis and treatment of an occult neoplasm. Rheumatic manifestations suggesting a hidden cancer include: rapid onset of an unusual inflammatory arthritis clubbing or diffuse bone pains in a patient 50 years of age or older, chronic unexplained vasculitis, refractory fasciitis, Raynaud's syndrome unresponsive to vasodilator therapy, rapidly progressive digital gangrene or Lambert-Eaton myasthenic syndrome. Management consists of control of the underlying cancer and symptomatic treatment of the rheumatic syndrome with non-steroidal anti-inflammatory drugs or corticosteroids.

Entities:  

Mesh:

Year:  2000        PMID: 10985984     DOI: 10.1053/berh.2000.0091

Source DB:  PubMed          Journal:  Baillieres Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  21 in total

1.  Prevalence of paraneoplastic rheumatic syndromes and their antibody profile among patients with solid tumours.

Authors:  Rita Rugienė; Jolanta Dadonienė; Eduardas Aleknavičius; Renatas Tikuišis; Jörg Distler; Georg Schett; Paulius Venalis; Algirdas Venalis
Journal:  Clin Rheumatol       Date:  2011-01-12       Impact factor: 2.980

2.  Circulating microparticles bearing Fibrin associated with whole-body 18FDG-PET: diagnostic tools to detect paraneoplastic polymyalgia rheumatica.

Authors:  Diane Mege; Serge Cammilleri; Olivier Mundler; Françoise Dignat-George; Christophe Dubois; Laurence Panicot-Dubois; Sandrine Guis
Journal:  Rheumatol Int       Date:  2016-06-20       Impact factor: 2.631

3.  Rheumatic-like syndrome as a symptom of underlying gastric cancer.

Authors:  C Papagoras; J Kountouras; S Brilakis; D Chatzopoulos; C Zavos; A Topalidis
Journal:  Clin Rheumatol       Date:  2006-03-30       Impact factor: 2.980

4.  Paraneoplastic syndromes in patients with primary malignancies of the head and neck. Four cases and a review of the literature.

Authors:  L W J Baijens; J J Manni
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-06-29       Impact factor: 2.503

Review 5.  Paraneoplastic rheumatic syndromes: report of eight cases and review of literature.

Authors:  Jinane Hakkou; Samira Rostom; Rachid Bahiri; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2011-11-17       Impact factor: 2.631

6.  Cutaneous vasculitis as an initiating paraneoplastic symptom in Hodgkin lymphoma.

Authors:  Zsófia Simon; Tünde Tarr; László Tóth; Gabriella Szucs; Arpád Illés
Journal:  Rheumatol Int       Date:  2007-12-19       Impact factor: 2.631

7.  A patient with adult erythermalgia: evidence suggesting an autoimmune etiology.

Authors:  Autumn L Jackson; John A Oates
Journal:  Am J Med Sci       Date:  2008-04       Impact factor: 2.378

8.  Cutaneous vasculitis in breast cancer treated with chemotherapy.

Authors:  Maida Wong; Jennifer Grossman; Bevra H Hahn; Antonio La Cava
Journal:  Clin Immunol       Date:  2008-07-21       Impact factor: 3.969

9.  Whole-Body (18) FDG-PET in an Arthritis Paraneoplastic Syndrome Revealed an Underlying Hematological Neoplasm.

Authors:  Serge Cammilleri; Marie Caroline Guzian; Jean-Pierre Mattei; Olivier Mundler; Sandrine Guis
Journal:  Case Rep Med       Date:  2013-06-02

10.  Musculoskeletal manifestations in patients with malignant disease.

Authors:  Tamer A Gheita; Yasser Ezzat; Safaa Sayed; Ghada El-Mardenly; Waleed Hammam
Journal:  Clin Rheumatol       Date:  2009-11-08       Impact factor: 3.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.